Noile-Immune Biotech: Additional comments on the cancellation of the NIB102 and NIB103 license agreements

JPX · Dec 15, 2023 18:45

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.